Sueldos y Compensación en Terns Pharmaceuticals

Terns Pharmaceuticals is a biopharmaceutical company focused on developing small-molecule therapies for cancer, NASH, and obesity. Their lead candidate, TERN-701, is being developed for chronic myeloid leukemia. They also have candidates in clinical trials for NASH and metabolic diseases. The company was founded in 2016 and is based in Foster City, California.